Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Acute respiratory failure? 361 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Acute respiratory failure have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.3% of all adverse event reports for RIVAROXABAN.

361
Reports of Acute respiratory failure with RIVAROXABAN
0.3%
of all RIVAROXABAN reports
202
Deaths
344
Hospitalizations

How Dangerous Is Acute respiratory failure From RIVAROXABAN?

Of the 361 reports, 202 (56.0%) resulted in death, 344 (95.3%) required hospitalization, and 112 (31.0%) were considered life-threatening.

Is Acute respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 361 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Acute respiratory failure?

PREDNISONE (645) TREPROSTINIL (484) MACITENTAN (422) TACROLIMUS (414) AMBRISENTAN (402) DEXAMETHASONE (384) RITUXIMAB (351) MYCOPHENOLATE MOFETIL (347) METHOTREXATE (321) METHYLPREDNISOLONE (317)

Which RIVAROXABAN Alternatives Have Lower Acute respiratory failure Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Acute respiratory failure Reports All Drugs Causing Acute respiratory failure RIVAROXABAN Demographics